Skip to main content
Log in

Miniaturized biocompatible cardiopulmonary bypass for the Fontan procedure

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Postoperative inflammatory response and perioperative systemic edema are the risks of failed Fontan circulation. We evaluated the efficiency of the miniaturized, poly-2-methoxyethylacrylate (PMEA)-coated cardiopulmonary bypass (CPB) circuit, which we devised in 2003, in the Fontan circulation.

Methods

Thirty-seven patients who underwent the Fontan procedure between March 1996 and December 2006 were divided into two groups: one consisting of patients with a priming-volume >250 m on uncoated conventional bypass (group C; n = 20), and one consisting of those with miniaturized (<200 ml) and PMEA-coated circuits (group M; n = 17). We compared the body weight gain (%BWG), minimum platelet count, maximum postoperative C-reactive protein (CRP), and minimum hematocrit (Hct) levels during the operation, maximum white blood cell (WBC) count, and postoperative pleural effusion, between the two groups. Stepwise multiple logistic regression analyses were used to investigate the most affecting factors.

Results

The %BWG and CRP levels were significantly lower in group M (P = 0.047 and P = 0.012, respectively). The minimum platelet count was significantly higher in group M (P = 0.012). There were no significant differences in postoperative pleural effusion, minimum Hct, or maximum WBC.

Conclusion

The miniaturized biocompatible CPB system reduced perioperative inflammatory responses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miyaji K, Miyamoto T, Kohira S, Nakashima K, Inoue N, Sato H, et al. Miniaturized cardiopulmonary bypass system in neonates and small infants. Interact Cardiovasc Thorac Surg 2008;7:75–79.

    Article  PubMed  Google Scholar 

  2. Miyaji K, Kohira S, Miyamoto T, Nakashima K, Sato H, Ohara K, et al. Pediatric cardiac surgery without homologous blood transfusion, using a miniaturized bypass system in infants with lower body weight. J Thorac Cardiovasc Surg 2007;134:284–289.

    Article  PubMed  Google Scholar 

  3. Ninomiya M, Miyaji K, Takamoto S. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg 2003;75:913–918.

    Article  PubMed  Google Scholar 

  4. Gaynor JW, Bridges ND, Cohen MI, Mahle WT, Decampli WM, Steven JM, et al. Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? J Thorac Cardiovasc Surg 2002;123:237–245.

    Article  PubMed  Google Scholar 

  5. Burkhart HM, Dearani JA, Williams WG, Puga FJ, Mair DD, Ashburn DA, et al. The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg 2003;125:1252–1259.

    Article  PubMed  Google Scholar 

  6. Ikuta T, Fujii H, Shibata T, Hattori K, Hirai H, Kumano H, et al. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg 2004;77:1678–1683.

    Article  PubMed  Google Scholar 

  7. Kutay V, Noyan T, Ozcan S, Melek Y, Ekim H, Yakut C. Biocompatibility of heparin-coated cardiopulmonary bypass circuit in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. J Card Surg 2006;21:572–577.

    Article  PubMed  Google Scholar 

  8. Huebler M, Boettcher W, Koster A, Emeis M, Lange P, Hetzer R. Transfusion-free complex cardiac surgery with cardiopulmonary bypass in a 3.55-kg Jehovah’s Witness neonate. Ann Thorac Surg 2005;80:1504–1506.

    Article  PubMed  Google Scholar 

  9. Beghi C, Nicolini F, Agostinelli A, Borrello B, Budillon AM, Bacciottini F, et al. Mini-cardiopulmonary bypass system: results of a prospective randomized study. Ann Thorac Surg 2006;81:1396–1400.

    Article  PubMed  Google Scholar 

  10. Abdel-Rahman U, Ozaslan F, Risteski PS, Martens S, Moritz A, Al Daraghmeh A, et al. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit? Ann Thorac Surg 2005;80:238–243.

    Article  PubMed  Google Scholar 

  11. Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P, et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002;22:527–533.

    Article  PubMed  Google Scholar 

  12. Remadi JP, Marticho P, Butoi I, Rakotoarivelo Z, Trojette F, Benamar A, et al. Clinical experience with the mini-extracorporeal circulation system: an evolution or a revolution? Ann Thorac Surg 2004;77:2172–2176.

    Article  PubMed  Google Scholar 

  13. Shiraishi S, Uemura H, Kagisaki K, Koh M, Yagihara T, Kitamura S. The off-pump Fontan procedure by simply cross-clamping the inferior caval vein. Ann Thorac Surg 2005;79:2083–2088.

    Article  PubMed  Google Scholar 

  14. Kawahira Y, Uemura H, Yagihara T. Impact of the off-pump Fontan procedure on complement activation and cytokine generation. Ann Thorac Surg 2006;81:685–689.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Itatani, K., Miyaji, K., Miyamoto, T. et al. Miniaturized biocompatible cardiopulmonary bypass for the Fontan procedure. Surg Today 40, 1040–1045 (2010). https://doi.org/10.1007/s00595-009-4178-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-009-4178-3

Key words

Navigation